Department of Gastroenterological Endoscopy, Tokyo Medical University, Tokyo, Japan.
Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan.
J Gastroenterol Hepatol. 2021 Jul;36(7):1738-1743. doi: 10.1111/jgh.15370. Epub 2021 Jan 31.
Either clipping or band ligation will become the most common endoscopic treatment for colonic diverticular bleeding (CDB). Rebleeding is a significant clinical outcome of CDB, but there is no cumulative evidence comparing reduction of short-term and long-term rebleeding between them. Thus, we conducted a systematic review and meta-analysis to determine which endoscopic treatment is more effective to reduce recurrence of CDB.
A comprehensive search of the databases PubMed/MEDLINE and Embase was performed through December 2019. Main outcomes were early and late rebleeding rates, defined as bleeding within 30 days and 1 year of endoscopic therapy for CDB. Initial hemostasis, need for transcatheter arterial embolization, or surgery were also assessed. Overall pooled estimates were calculated.
Sixteen studies fulfilled the eligibility criteria, and a total of 790 participants were included. The pooled prevalence of early rebleeding was significantly lower for band ligation than clipping (0.08 vs 0.19; heterogeneity test, P = 0.012). The pooled prevalence of late rebleeding was significantly lower for band ligation than clipping (0.09 vs 0.29; heterogeneity test, P = 0.024). No significant difference of initial hemostasis rate was noted between the two groups. Pooled prevalence of need for transcatheter arterial embolization or surgery was significantly lower for band ligation than clipping (0.01 vs 0.02; heterogeneity test, P = 0.031). There were two cases with colonic diverticulitis due to band ligation but none in clipping.
Band ligation therapy was more effective compared with clipping to reduce recurrence of colonic diverticular hemorrhage over short-term and long-term durations.
夹闭或结扎都将成为结肠憩室出血(CDB)最常见的内镜治疗方法。再出血是 CDB 的一个重要临床转归,但目前尚无比较两者之间短期和长期再出血减少效果的累积证据。因此,我们进行了一项系统评价和荟萃分析,以确定哪种内镜治疗方法更能有效减少 CDB 的复发。
通过 2019 年 12 月对 PubMed/MEDLINE 和 Embase 数据库进行全面检索。主要结局是早期和晚期再出血率,定义为内镜治疗 CDB 后 30 天内和 1 年内的出血。还评估了初始止血、经导管动脉栓塞术或手术的需要。计算了总体汇总估计值。
16 项研究符合纳入标准,共纳入 790 名参与者。结扎的早期再出血发生率明显低于夹闭(0.08 比 0.19;异质性检验,P = 0.012)。结扎的晚期再出血发生率明显低于夹闭(0.09 比 0.29;异质性检验,P = 0.024)。两组初始止血率无显著差异。结扎的经导管动脉栓塞术或手术需要率明显低于夹闭(0.01 比 0.02;异质性检验,P = 0.031)。结扎有 2 例因结肠憩室炎导致,而夹闭组则无。
与夹闭相比,结扎治疗在短期和长期内更能有效减少结肠憩室出血的复发。